alpha-fluoro-beta-alanine has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bridgewater, J; Grange, S; Kimura, M; Kuranami, M; Lucraft, H; McAleer, J; Monkhouse, J; Poole, C; Reigner, B; Saeki, T; Sasaki, Y; Schüller, J; Watanabe, T; Weidekamm, E; Yorulmaz, C | 1 |
| Diasio, RB; Schuetz, JD; Sommadossi, JP; Wallace, HJ | 1 |
1 trial(s) available for alpha-fluoro-beta-alanine and Breast Cancer
| Article | Year |
|---|---|
Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Area Under Curve; beta-Alanine; Biotransformation; Breast Neoplasms; Capecitabine; Deoxycytidine; Female; Fluorouracil; Half-Life; Humans; Japan; Metabolic Clearance Rate; Middle Aged; Tissue Distribution; White People | 2003 |
1 other study(ies) available for alpha-fluoro-beta-alanine and Breast Cancer
| Article | Year |
|---|---|
Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells.
Topics: Animals; Antineoplastic Agents; beta-Alanine; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Cell Line; Cell Survival; Female; Fluorouracil; Humans; Male; Mice; Mice, Inbred Strains; Thymidylate Synthase | 1985 |